Literature DB >> 1711411

Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.

F H de Jong1, K Oishi, R B Hayes, J F Bogdanowicz, J W Raatgever, P J van der Maas, O Yoshida, F H Schroeder.   

Abstract

The possible relationship between changes in peripheral hormone levels and the occurrence of prostatic pathology was studied in a case-control study, involving estimation of various plasma hormones in 368 Dutch and 258 Japanese men, who were grouped as controls and patients with benign prostatic hyperplasia, focal prostatic carcinoma, or clinically evident prostatic carcinoma. Results of a number of previous, smaller studies concerning interrelationships between hormone levels in elderly men were confirmed within the Dutch and Japanese groups. Plasma levels of testosterone and estradiol were significantly lower in the Japanese men, when compared with those in Dutch men. Probably as a result of this difference in testosterone levels, the ratio between serum levels of testosterone and sex hormone-binding globulin (SHBG) was decreased in the Japanese men, while the ratio between the concentrations of dihydrotestosterone and testosterone was increased. These differences were also found when results from Japanese subgroups (controls and patients with prostate pathology) were compared with those from the Dutch subgroups. There were no significant differences in plasma androgen levels between Japanese or Dutch prostate cancer cases and their respective control subgroups. These findings do not support a correlation between the lower plasma testosterone levels and a lower incidence of prostate cancer in the Japanese men. Furthermore, no significant differences were found between salivary levels of testosterone or the ratio between testosterone and SHBG in the various Dutch subgroups. In Japanese benign prostatic hyperplasia patients, the testosterone to SHBG ratio was significantly increased. In conclusion, the results of this retrospective, cross-sectional study do not indicate that hormonal levels play a primary role in the origin or promotion of prostatic abnormalities. The finding of a lower plasma testosterone in the Japanese men, however, remains suggestive, warranting a more extensive prospective study.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711411

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

Review 1.  Racial differences in the androgen/androgen receptor pathway in prostate cancer.

Authors:  C A Pettaway
Journal:  J Natl Med Assoc       Date:  1999-12       Impact factor: 1.798

2.  Serum Testosterone, 17β-Estradiol and PSA Levels in Subjects with Prostate Disorders.

Authors:  Anthony J Usoro; Aniebietabasi S Obot; Itemobong S Ekaidem; Okon E Akaiso; Alphonsus E Udoh; O Akinloye
Journal:  Indian J Clin Biochem       Date:  2014-01-29

Review 3.  Nutrition and prostate cancer.

Authors:  L N Kolonel
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

Review 4.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

5.  Association between race and oncologic outcome following radical prostatectomy for clinically organ-confined prostate cancer: a long-term follow-up study.

Authors:  Erfan Amini; Tracy Campanelli Palmer; Jie Cai; Gary Lieskovsky; Siamak Daneshmand; Hooman Djaladat
Journal:  World J Urol       Date:  2018-03-13       Impact factor: 4.226

6.  Challenges with luteinizing hormone-releasing hormone agonists: flare and surge.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2004

7.  Androgen supplementation and prostate cancer risk: strategies for pretherapy assessment and monitoring.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2003

Review 8.  The safety of vasectomy: recent concerns.

Authors:  T M Farley; O Meirik; S Mehta; G M Waites
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

9.  Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy.

Authors:  Stuart J Ellem; Hong Wang; Matti Poutanen; Gail P Risbridger
Journal:  Am J Pathol       Date:  2009-08-21       Impact factor: 4.307

10.  Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial.

Authors:  Alan R Kristal; Jeannette M Schenk; YoonJu Song; Kathryn B Arnold; Marian L Neuhouser; Phyllis J Goodman; Daniel W Lin; Frank Z Stanczyk; Ian M Thompson
Journal:  Am J Epidemiol       Date:  2008-10-21       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.